These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7584910)

  • 41. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients.
    Hussein O; Shneider J; Rosenblat M; Aviram M
    J Cardiovasc Pharmacol; 2002 Jul; 40(1):28-34. PubMed ID: 12072574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells.
    Lesnik P; Dachet C; Petit L; Moreau M; Griglio S; Brudi P; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):979-88. PubMed ID: 9157964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein.
    Miura S; Watanabe J; Tomita T; Sano M; Tomita I
    Biol Pharm Bull; 1994 Dec; 17(12):1567-72. PubMed ID: 7735196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
    Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
    Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper.
    Yan LJ; Droy-Lefaix MT; Packer L
    Biochem Biophys Res Commun; 1995 Jul; 212(2):360-6. PubMed ID: 7626049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antioxidative effects of cichorium intybus root extract on LDL (low density lipoprotein) oxidation.
    Kim TW; Yang KS
    Arch Pharm Res; 2001 Oct; 24(5):431-6. PubMed ID: 11693546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Properties of low density lipoproteins relevant to oxidative modifications change paradoxically during aging.
    Stulnig TM; Jürgens G; Chen Q; Moll D; Schönitzer D; Jarosch E; Wick G
    Atherosclerosis; 1996 Sep; 126(1):85-94. PubMed ID: 8879437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidation of low-density lipoproteins: effect of antioxidant content, fatty acid composition and intrinsic phospholipase activity on susceptibility to metal ion-induced oxidation.
    Croft KD; Williams P; Dimmitt S; Abu-Amsha R; Beilin LJ
    Biochim Biophys Acta; 1995 Feb; 1254(3):250-6. PubMed ID: 7857965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper.
    Spranger T; Finckh B; Fingerhut R; Kohlschütter A; Beisiegel U; Kontush A
    Chem Phys Lipids; 1998 Jan; 91(1):39-52. PubMed ID: 9488998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: a randomized, double-blind, placebo-controlled study.
    Yoshida H; Ishikawa T; Ayaori M; Shige H; Ito T; Suzukawa M; Nakamura H
    Atherosclerosis; 1998 Jul; 139(1):179-87. PubMed ID: 9699906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of lipid profile and fatty acid composition on the oxidation behavior of rat and guinea pig low density lipoprotein.
    Vázquez M; Merlos M; Adzet T; Laguna JC
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Feb; 119(2):311-6. PubMed ID: 9629664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Circulation; 2003 Aug; 108(7):808-13. PubMed ID: 12900341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Grape extract inhibits lipid peroxidation of human low density lipoprotein.
    Lanningham-Foster L; Chen C; Chance DS; Loo G
    Biol Pharm Bull; 1995 Oct; 18(10):1347-51. PubMed ID: 8593434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P; Ongsakul M; Proudfoot J; Croft K; Beilin L
    Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR; Loo G
    J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HDL3 exerts a more powerful antiperoxidative and protective effect against peroxidative modification of LDL than HDL2 does.
    Sakuma N; Yoshikawa M; Hibino T; Ohte N; Kamiya T; Kunimatsu M; Kimura G; Inoue M
    J Nutr Sci Vitaminol (Tokyo); 2002 Aug; 48(4):278-82. PubMed ID: 12489818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro.
    Kerry NL; Abbey M
    Atherosclerosis; 1997 Nov; 135(1):93-102. PubMed ID: 9395277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infection and inflammation induce LDL oxidation in vivo.
    Memon RA; Staprans I; Noor M; Holleran WM; Uchida Y; Moser AH; Feingold KR; Grunfeld C
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1536-42. PubMed ID: 10845869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oximes as inhibitors of low density lipoprotein oxidation.
    de Lima Portella R; Barcelos RP; de Bem AF; Carratu VS; Bresolin L; da Rocha JB; Soares FA
    Life Sci; 2008 Dec; 83(25-26):878-85. PubMed ID: 18992260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.